Virax Biolabs Group Share Price (NASDAQ: VRAX)
$0.78
▲
0.01
(1.3%)
Live
Last updated on
Check the interactive Virax Biolabs Group Stock chart to analyse performance
Virax Biolabs Group stock performance
as on August 19, 2025 at 12:34 AM IST
- Today's Low:$0.77Today's High:$0.78
1.67%
Downside
Day's Volatility :1.67%
Upside
0.0%
- 52 Weeks Low:$0.7252 Weeks High:$9.00
7.41%
Downside
52 Weeks Volatility :91.98%
Upside
91.33%
Virax Biolabs Group Stock Returns
Virax Biolabs Group Ltd Key Stats
Check Virax Biolabs Group key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Virax Biolabs Group Stock including INR - Dollar returns
The Virax Biolabs Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Virax Biolabs Group investment value today
Current value as on today
₹19,219
Returns
Returns from Virax Biolabs Group Stock
Dollar Returns*
₹4,073 (+4.07%)
Indian investors sentiment towards Virax Biolabs Group Stock
Global Institutional Holdings in Virax Biolabs Group Ltd
Name
Holdings %
UBS Group AG
0.52%
TWO SIGMA SECURITIES, LLC
0.31%
Citadel Advisors Llc
0.31%
HRT FINANCIAL LLC
0.31%
Analyst Recommendation on Virax Biolabs Group Stock
Virax Biolabs Group Share Price Target
What analysts predicted
Upside of 284.62%
Target:
$3.00
Current:
$0.78
Virax Biolabs Group share price target is $3.00, a slight Upside of 284.62% compared to current price of $0.78 as per analysts' prediction.
Virax Biolabs Group Stock Insights
Price Movement
In the last 3 months, VRAX stock has moved down by -28.3%Decreasing Revenue
Revenue is down for the last 2 quarters, 79.91K → 4.95K (in $), with an average decrease of 93.8% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -3.82M → -2.75M (in $), with an average increase of 38.7% per quarterVRAX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.4% return, outperforming this stock by 131.0%VRAX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.9% return, outperforming this stock by 199.6%Price to Sales
ForVRAX every $1 of sales, investors are willing to pay $395.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.6 for every $1 of sales.
Virax Biolabs Group Technicals Summary
Sell
Neutral
Buy
Virax Biolabs Group is currently in a neutral trading position according to technical analysis indicators.
Virax Biolabs Group Ltd Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -30.2% | -58.79% | -84.96% | -98.6% | -99.57% |
 | 6.39% | -14.65% | -51.51% | -6.14% | -7.82% |
 | 10.08% | 34.96% | 66.94% | 83.8% | 36.85% |
 | -14.33% | -15.0% | -19.52% | 31.35% | 45.44% |
 | 40.06% | 79.56% | 63.55% | 107.86% | 227.15% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.48 | -1.14 | -0.65 | NA | 1.31 |
| 14.62 | 14.62 | 1.19 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.33 | -0.05 | -0.01 | NA | 34.32 |
| 27.94 | 27.94 | 0.58 | 18.04 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| NA | $3.4M | -99.57% | NA | 0.0% |
| Buy | $61.5B | -7.82% | 14.62 | 31.37% |
| NA | $38.8B | 36.85% | NA | -3.89% |
| Buy | $100.7B | 45.44% | 27.94 | 31.86% |
| Buy | $58.0B | 227.15% | NA | -12.96% |
About Virax Biolabs Group Ltd
Key Management of Virax Biolabs Group Ltd
Important FAQs about investing in VRAX Stock from India :
What is Virax Biolabs Group share price today?
Virax Biolabs Group share price today is $0.78 as on . Virax Biolabs Group share today touched a day high of $0.78 and a low of $0.77.
What is the 52 week high and 52 week low for Virax Biolabs Group share?
Virax Biolabs Group share touched a 52 week high of $9.00 and a 52 week low of $0.72. Virax Biolabs Group stock price today, is trending at $0.78, lower by 91.33% versus the 52 week high.
How to invest in Virax Biolabs Group Stock (VRAX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Virax Biolabs Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Virax Biolabs Group Shares that will get you 1.9231 shares as per Virax Biolabs Group share price of $0.78 per share as on August 19, 2025 at 12:34 AM IST.
What is the minimum amount required to buy Virax Biolabs Group Stock (VRAX) from India?
Indian investors can start investing in Virax Biolabs Group (VRAX) shares with as little as ₹87.3775 or $1 (as of August 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹873.77 in Virax Biolabs Group stock (as per the Rupee-Dollar exchange rate as on August 18, 2025).
Based on Virax Biolabs Group share’s latest price of $0.78 as on August 19, 2025 at 12:34 AM IST, you will get 12.8205 shares of Virax Biolabs Group. Learn more about
fractional shares .
What are the returns that Virax Biolabs Group has given to Indian investors in the last 5 years?
Virax Biolabs Group stock has given -99.57% share price returns and 16.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?
Discover More
Universal Technical Institute Inc$26.40
+1.42%
Dakota Gold Corp$4.00
+0.25%
- Creative Global Technology Holdings Limited
$0.72
-6.49%
- Aam Slc Low Duration Income Etf
$25.25
-0.08%
- Atac Us Rotation Etf
$15.50
-0.83%
Yieldmax Msft Option Income Strategy Etf$17.95
-0.83%
- Defiance D Trgt 2x L Jpm Etf
$19.10
+0.63%
